Imricor Adds First Site in Greece

Karen BorresenNews

4 January 2022 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, is pleased to announce that the Henry Dunant Hospital Centre in Athens, Greece (https://www.dunant.gr/en/) is the latest institution to adopt Imricor’s iCMR ablation solutions.

Imricor Enrolls Two More Customer Sites in Berlin

Karen BorresenNews

28 December 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, is pleased to announce that the German Heart Centre Berlin (https://www.dhzb.de/en/), and the Charité Medical University, Virchow-Klinikum Campus (Charité) (https://www.charite.de/en/), both in Berlin, Germany, are the latest two institutions to adopt Imricor’s iCMR ablation solutions.

Semmelweis University Heart and Vascular Centre Established as Imricor’s Eleventh iCMR Site

Karen BorresenNews

13 October 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in iCMR-guided cardiac ablation products, is pleased to announce that the Semmelweis University Heart and Vascular Centre in Budapest Hungary, has signed a purchase agreement with Imricor, making it the eleventh site to establish an iCMR lab to perform ablations with Imricor’s products.

Imricor Announces Sales Agreement with NordicNeuroLab

Karen BorresenNews

30 August 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce it has entered into a Sales Distribution Agreement with NordicNeuroLab AS, a leading maker of MRI compatible in-room monitors, headquartered in Norway.

Imricor’s Advantage-MR System Receives TGA Approval

Karen BorresenNews

lobal leader in MRI-guided cardiac ablation products, has achieved an important milestone in its geographic expansion plans with the Company’s Advantage-MR EP Recorder/Stimulator system receiving Australian TGA approval.

Leipzig Heart Centre Commences Procedures

Karen BorresenNews

8 March 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce the Helios Leipzig Heart Centre in Germany has commenced procedures.

Maastricht Univerisity Medical Center Commences Procedures

Karen BorresenNews

24 February 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce the Maastricht University Medical Centre+ (MUMC+) in the Netherlands has commenced procedures since the extended lockdowns across Europe precluded elective surgeries. The team at MUMC+ successfully performed two atrial flutter ablations yesterday.

Imricor Appoints Chief Operating Officer

Karen BorresenNews

29 December 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products Imricor is pleased to announce that to support the Company’s future growth strategy, Mr Gregg Stenzel has been appointed to the role of Chief Operating Officer, effective 1 January 2021. In this newly established role, Mr Stenzel will lead the execution of Imricor’s strategic plan across most functional areas of the business, providing greater capacity for CEO, Steve Wedan, to drive the establishment of new clinical sites as the business accelerates the commercial roll-out of its products across Europe in 2021.

Imricor Announces Supply and Sales Agreement with Osypka

Karen BorresenNews

10 December 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce they have entered into a Supply and Sales Agreement with Osypka AG Medizintechnik (Osypka), a German producer of radiofrequency ablation generators.